Resectable Oesophageal Cancer: a Practice Guideline Update. Practice Changing or Supporting the Status Quo?

Clinical Oncology

Volume 22, Issue 4, May 2010, Pages 247-249

V. Gebski et al.
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
Lancet Oncol
(2007)
J.D. Urschel et al.
A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer
Am J Surg
(2003)
R. Malthaner et al.
Gastrointestinal cancer disease site group. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis
BMC Med
(2004)
R. Malthaner et al.
Gastrointestinal Cancer Disease Site Group. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline
BMC Cancer
(2004)
G.P. Browman et al.
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation
J Clin Oncol
(1995)
P.G. Thirion et al.
Individual patient data-based metaanalysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma
J Clin Oncol
(2007)
J. Blazeby et al.
A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma
Cancer
(2000 Apr)

There are more references available in the full text version of this article.